Story perspectives

Breakthrough Discovery: Gene GATA6 Boosts Pancreatic Cancer Treatment

3/4/2026

Summary

Story summary

Researchers at Duke-NUS Medical School identified a molecular switch involving the gene GATA6 that governs pancreatic cancer cells' response to chemotherapy.
When GATA6 levels drop, pancreatic tumors become more aggressive and resistant to treatment.
Blocking the KRAS and ERK pathways restores GATA6 levels and increases chemotherapy responsiveness.
Combining these targeted therapies with standard chemotherapy enhances effects, and the findings may apply to other KRAS-driven cancers.

1 of 1

Story summary

Researchers at Duke-NUS Medical School identified a molecular switch involving the gene GATA6 that governs pancreatic cancer cells' response to chemotherapy.
When GATA6 levels drop, pancreatic tumors become more aggressive and resistant to treatment.
Blocking the KRAS and ERK pathways restores GATA6 levels and increases chemotherapy responsiveness.
Combining these targeted therapies with standard chemotherapy enhances effects, and the findings may apply to other KRAS-driven cancers.